Teddy's campaign

Teddy loves riding trains, going to the station to see the trains, playing with his train set, and watching Thomas and Friends. He is a very funny and clever little boy and is always known by the nurses and doctors for being chatty and singing the Thomas theme tune! 

In July 2022, Teddy was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. 

His parents, Katherine and Alastair, started fundraising to fulfil their wishes for Teddy to access the DFMO study at Penn State Children's Hospital after he finished frontline treatment, with the hope of keeping the cancer away. Thanks to the incredible support the campaign received, Teddy was able to enrol on the study in February 2024.

Teddy’s campaign remains open in case he needs potentially life-saving treatment in the future not available through the NHS, which could cost hundreds of thousands of pounds. Follow his story on social media.

Teddy’s story 

In June 2022, Teddy had just turned three and had become a big brother to baby Rupert. Throughout the summer, the family made multiple trips to the GP with Teddy due to fevers, discomfort and crying at night - first, it was tonsillitis, then an ear infection, which both cleared up with antibiotics. He was lethargic and had a low appetite but that wasn't unexpected given the infections. Then on 26th June, Teddy said 'my sides hurt' for the first time. 

The next day, Katherine took him to the doctor, who examined him thoroughly and was happy with his condition. Afterwards, Teddy spent hours running around and playing at soft play like every other child. During the night, he cried continuously whilst his mum held him and moaned 'mummy I'm tired, mummy it hurts'. His mum knew something was very wrong.  

Alastair took him to the hospital the next morning – he was admitted with suspected appendicitis but discharged the next day. A few days later though the pain came back, and he was once again admitted after going to A&E. After a few days, because his infection markers were rising but no source of infection had been found, he was given an ultrasound. 

Treatment so far 

The next weeks were a blur of biopsies, scans and blood tests. Teddy's parents were told that his neuroblastoma was metastatic high-risk, with only a 40% chance of survival at diagnosis. Teddy and Alastair spent nearly five weeks moving between three hospitals, while Kat bounced between various hospital accommodations and home with their four-month-old before Teddy was finally discharged after his first round of induction chemotherapy.  

Since diagnosis, Teddy has had a central line fitted, a biopsy, multiple general anaesthetics for bone marrow aspirates and scans, 14 NG tube insertions, six gruelling rounds of induction chemotherapy and multiple admissions to his local hospital for fevers. He was also randomised on a trial to receive a tandem transplant, which meant he had two stem cell harvests, two rounds of high-dose chemotherapy and stem cell transplants. The trial that he’s on also means he has been randomised to receive additional radiotherapy to his primary tumour, which couldn't be removed with surgery due to its position, so he'll have 20 days of radiotherapy instead of 12.  

After this, surgery will be reviewed again, and Teddy will complete his frontline treatment with six months of immunotherapy.  

Download fundraising materials

Order fundraising resources 

Order your collection tins and buckets and charity wristbands to support your fundraising. 

_{Solving Kids' Cancer UK's children's fundraising campaigns} 

_{Funds raised will go towards helping Teddy and his family. If Teddy no longer needs the funds or is in remission five years post the end of successful treatment, the funds will be used to support other children and families affected by neuroblastoma through our activities. For children with high-risk neuroblastoma, like Teddy, the survival rate is much lower than other childhood cancers. Upon relapse, this rate reduces even further.}